vs
Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and SOLENO THERAPEUTICS INC (SLNO). Click either name above to swap in a different company.
HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $66.0M, roughly 1.4× SOLENO THERAPEUTICS INC). SOLENO THERAPEUTICS INC runs the higher net margin — 39.4% vs -98.1%, a 137.5% gap on every dollar of revenue.
Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.
SOLENO THERAPEUTICS INC is a clinical-stage biopharmaceutical company specializing in developing novel therapies for rare endocrine, metabolic, and neurodevelopmental disorders. Its lead product candidate targets Prader-Willi syndrome, a rare genetic condition, with key patient markets across North America and the European Union.
HIVE vs SLNO — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $93.1M | $66.0M |
| Net Profit | $-91.3M | $26.0M |
| Gross Margin | -27.1% | 98.3% |
| Operating Margin | — | 33.5% |
| Net Margin | -98.1% | 39.4% |
| Revenue YoY | 218.6% | — |
| Net Profit YoY | -234.0% | 134.0% |
| EPS (diluted) | $-0.38 | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $93.1M | — | ||
| Q3 25 | $87.3M | $66.0M | ||
| Q2 25 | $45.6M | $32.7M | ||
| Q4 24 | $29.2M | — | ||
| Q3 24 | $22.6M | — | ||
| Q2 24 | $32.2M | — | ||
| Q4 23 | $22.8M | — |
| Q4 25 | $-91.3M | — | ||
| Q3 25 | $-15.8M | $26.0M | ||
| Q2 25 | $35.0M | $-4.7M | ||
| Q4 24 | $68.2M | — | ||
| Q3 24 | $80.0K | — | ||
| Q2 24 | $-18.3M | — | ||
| Q4 23 | $-24.5M | — |
| Q4 25 | -27.1% | — | ||
| Q3 25 | 4.7% | 98.3% | ||
| Q2 25 | -13.6% | 97.9% | ||
| Q4 24 | -43.7% | — | ||
| Q3 24 | -66.1% | — | ||
| Q2 24 | -7.4% | — | ||
| Q4 23 | -52.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | -20.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | -98.1% | — | ||
| Q3 25 | -18.1% | 39.4% | ||
| Q2 25 | 76.8% | -14.4% | ||
| Q4 24 | 233.2% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | -56.7% | — | ||
| Q4 23 | -107.8% | — |
| Q4 25 | $-0.38 | — | ||
| Q3 25 | $-0.07 | $0.47 | ||
| Q2 25 | $0.18 | $-0.09 | ||
| Q4 24 | $0.52 | — | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $-0.17 | — | ||
| Q4 23 | $-0.29 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $498.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $559.3M | $494.8M |
| Total Assets | $624.0M | $599.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $498.9M | ||
| Q2 25 | — | $286.8M | ||
| Q4 24 | $40.5M | — | ||
| Q3 24 | $31.7M | — | ||
| Q2 24 | — | — | ||
| Q4 23 | $4.5M | — |
| Q4 25 | $559.3M | — | ||
| Q3 25 | $624.6M | $494.8M | ||
| Q2 25 | $560.5M | $240.1M | ||
| Q4 24 | $430.9M | — | ||
| Q3 24 | $275.5M | — | ||
| Q2 24 | $268.6M | — | ||
| Q4 23 | $122.9M | — |
| Q4 25 | $624.0M | — | ||
| Q3 25 | $693.0M | $599.9M | ||
| Q2 25 | $628.7M | $332.3M | ||
| Q4 24 | $478.6M | — | ||
| Q3 24 | $334.7M | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $46.0M | $43.5M |
| Free Cash FlowOCF − Capex | — | $43.5M |
| FCF MarginFCF / Revenue | — | 65.8% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $46.0M | — | ||
| Q3 25 | $-10.6M | $43.5M | ||
| Q2 25 | $10.2M | $-12.6M | ||
| Q4 24 | $-28.5M | — | ||
| Q3 24 | $-2.2M | — | ||
| Q2 24 | $-4.4M | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $43.5M | ||
| Q2 25 | — | $-12.6M | ||
| Q4 24 | $-55.5M | — | ||
| Q3 24 | $-34.7M | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 65.8% | ||
| Q2 25 | — | -38.6% | ||
| Q4 24 | -189.9% | — | ||
| Q3 24 | -153.4% | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 143.9% | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.67× | ||
| Q2 25 | 0.29× | — | ||
| Q4 24 | -0.42× | — | ||
| Q3 24 | -26.94× | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
